BGP advises HBM Healthcare Investments

28. April 2017

BGP advises HBM Healthcare Investments regarding a EUR 20 Mio. Investment in Amicus Ltd 

HBM Healthcare Investments made a new equity investment of EUR 20 million in two tranches into the privately held and Switzerland based Amicus Ltd. The financing will allow Amicus Ltd to accelerate the growth of its pharmaceutical business in Central and Eastern Europe.

HBM Healthcare Investments invests in the healthcare sector and is listed on SIX Swiss Exchange (ticker: HBMN). The Company holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology and diagnostics sectors and related areas.

Bader Gnehm & Partner advised HBM Healthcare Investments with regards to all legal aspects of this transaction. The team was lead by Oliver Gnehm (Partner) and furthermore included Jürg Locher (Partner), Olivier Bula (Senior Associate) and Bastian Blank (Associate).